4//SEC Filing
Berkowitz Noah 4
Accession 0001655759-24-000040
CIK 0001655759other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:15 PM ET
Size
7.8 KB
Accession
0001655759-24-000040
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Berkowitz Noah
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-18+93,879→ 93,879 totalExercise: $42.60Exp: 2034-03-17→ Common Stock (93,879 underlying) - Award
Common Stock
2024-03-18+63,452→ 63,452 total
Footnotes (2)
- [F1]The restricted stock units (each, an "RSU") were granted by the Issuer on March 18, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4), and not pursuant to its 2018 Stock Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 25% of the RSUs will vest on each of March 18, 2025, March 18, 2026, March 18, 2027 and March 18, 2028, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- [F2]The option was granted by the Issuer on March 18, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4) and not pursuant the Plan. The shares underlying the option will vest over four years: 1/4 of the shares underlying the award shall vest on March 18, 2025, with the remainder of the shares vesting in equal monthly installments following March 18, 2025 through March 18, 2028.
Documents
Issuer
ARVINAS, INC.
CIK 0001655759
Entity typeother
Related Parties
1- filerCIK 0001369900
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:15 PM ET
- Size
- 7.8 KB